• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于识别脱靶受体毒性的体外/计算机模拟相结合的方法。

A Combined In Vitro/In Silico Approach to Identifying Off-Target Receptor Toxicity.

作者信息

Leedale Joseph, Sharkey Kieran J, Colley Helen E, Norton Áine M, Peeney David, Mason Chantelle L, Sathish Jean G, Murdoch Craig, Sharma Parveen, Webb Steven D

机构信息

EPSRC Liverpool Centre for Mathematics in Healthcare, Department of Mathematical Sciences, University of Liverpool, Liverpool L69 7ZL, UK.

EPSRC Liverpool Centre for Mathematics in Healthcare, Department of Mathematical Sciences, University of Liverpool, Liverpool L69 7ZL, UK.

出版信息

iScience. 2018 Jun 29;4:84-96. doi: 10.1016/j.isci.2018.05.012. Epub 2018 May 18.

DOI:10.1016/j.isci.2018.05.012
PMID:30240756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6147237/
Abstract

Many xenobiotics can bind to off-target receptors and cause toxicity via the dysregulation of downstream transcription factors. Identification of subsequent off-target toxicity in these chemicals has often required extensive chemical testing in animal models. An alternative, integrated in vitro/in silico approach for predicting toxic off-target functional responses is presented to refine in vitro receptor identification and reduce the burden on in vivo testing. As part of the methodology, mathematical modeling is used to mechanistically describe processes that regulate transcriptional activity following receptor-ligand binding informed by transcription factor signaling assays. Critical reactions in the signaling cascade are identified to highlight potential perturbation points in the biochemical network that can guide and optimize additional in vitro testing. A physiologically based pharmacokinetic model provides information on the timing and localization of different levels of receptor activation informing whole-body toxic potential resulting from off-target binding.

摘要

许多外源性物质可与脱靶受体结合,并通过下游转录因子的失调导致毒性。确定这些化学物质随后的脱靶毒性通常需要在动物模型中进行广泛的化学测试。本文提出了一种用于预测毒性脱靶功能反应的体外/计算机模拟相结合的替代方法,以优化体外受体鉴定并减轻体内测试的负担。作为该方法的一部分,数学模型用于从机制上描述在转录因子信号测定的指导下,受体-配体结合后调节转录活性的过程。识别信号级联中的关键反应,以突出生化网络中可能引导和优化额外体外测试的潜在扰动点。基于生理学的药代动力学模型提供了不同水平受体激活的时间和定位信息,从而了解脱靶结合导致的全身毒性潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/791f33be1022/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/48a5488bf08a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/43c45c8fcc44/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/9476d25e3932/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/a2157618009a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/ff5dab9691b4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/7c7b506c0490/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/791f33be1022/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/48a5488bf08a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/43c45c8fcc44/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/9476d25e3932/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/a2157618009a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/ff5dab9691b4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/7c7b506c0490/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/6147237/791f33be1022/gr6.jpg

相似文献

1
A Combined In Vitro/In Silico Approach to Identifying Off-Target Receptor Toxicity.一种用于识别脱靶受体毒性的体外/计算机模拟相结合的方法。
iScience. 2018 Jun 29;4:84-96. doi: 10.1016/j.isci.2018.05.012. Epub 2018 May 18.
2
Mapping physiology: A systems biology approach for the development of alternative methods in toxicology.生理学映射:一种用于毒理学替代方法开发的系统生物学方法。
ALTEX. 2025;42(2):301-307. doi: 10.14573/altex.2412241. Epub 2025 Jan 20.
3
Bridging the Data Gap From Toxicity Testing to Chemical Safety Assessment Through Computational Modeling.通过计算建模弥合从毒性测试到化学安全评估的数据差距。
Front Public Health. 2018 Sep 11;6:261. doi: 10.3389/fpubh.2018.00261. eCollection 2018.
4
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.转基因植物及其衍生食品和饲料的安全性与营养评估:动物饲养试验的作用
Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13.
5
Application of an Accessible Interface for Pharmacokinetic Modeling and to Extrapolation.用于药代动力学建模和外推的可访问接口的应用。
Front Pharmacol. 2022 Apr 13;13:864742. doi: 10.3389/fphar.2022.864742. eCollection 2022.
6
Predicting the future: opportunities and challenges for the chemical industry to apply 21st-century toxicity testing.预测未来:化学工业应用21世纪毒性测试的机遇与挑战。
J Am Assoc Lab Anim Sci. 2015 Mar;54(2):214-23.
7
Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity.信息依赖富集分析揭示了毒性雌激素途径的时间依赖性转录调控。
Arch Toxicol. 2017 Apr;91(4):1749-1762. doi: 10.1007/s00204-016-1824-6. Epub 2016 Sep 3.
8
A conceptual framework for predicting the toxicity of reactive chemicals: modeling soft electrophilicity.预测活性化学品毒性的概念框架:软亲电性建模
SAR QSAR Environ Res. 2006 Aug;17(4):413-28. doi: 10.1080/10629360600884371.
9
Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.美国环保署实施的计算毒理学:为筛选和评估化学暴露、危害和风险提供高通量决策支持工具。
J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):197-217. doi: 10.1080/10937404.2010.483935.
10
Dietary glycation compounds - implications for human health.饮食糖化化合物 - 对人类健康的影响。
Crit Rev Toxicol. 2024 Sep;54(8):485-617. doi: 10.1080/10408444.2024.2362985. Epub 2024 Aug 16.

引用本文的文献

1
The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery.从药物发现中ADME评价角度看计算机模拟模型的趋势与未来展望
Pharmaceutics. 2023 Nov 12;15(11):2619. doi: 10.3390/pharmaceutics15112619.

本文引用的文献

1
Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates.用于研究人类肝功能以及评估药物和候选药物肝毒性的新型三维培养系统
Chem Res Toxicol. 2016 Dec 19;29(12):1936-1955. doi: 10.1021/acs.chemrestox.6b00150. Epub 2016 Sep 23.
2
Stochastic Petri Net Modeling of Hypoxia Pathway Predicts a Novel Incoherent Feed-Forward Loop Controlling SDF-1 Expression in Acute Kidney Injury.缺氧通路的随机Petri网建模预测了一种新型的非相干前馈环,该环控制急性肾损伤中SDF-1的表达。
IEEE Trans Nanobioscience. 2016 Jan;15(1):19-26. doi: 10.1109/TNB.2015.2509475. Epub 2015 Dec 18.
3
Regulatory Mechanisms of Endoplasmic Reticulum Resident IP3 Receptors.
内质网驻留肌醇三磷酸受体的调节机制
J Mol Neurosci. 2015 Aug;56(4):938-948. doi: 10.1007/s12031-015-0551-4. Epub 2015 Apr 10.
4
Structure/function relationships of phospholipases C Beta.磷脂酶 Cβ的结构/功能关系。
Curr Protein Pept Sci. 2013 Dec;14(8):650-7. doi: 10.2174/13892037113146660085.
5
A European perspective on alternatives to animal testing for environmental hazard identification and risk assessment.欧洲对用于环境危害识别与风险评估的动物试验替代方法的观点。
Regul Toxicol Pharmacol. 2013 Dec;67(3):506-30. doi: 10.1016/j.yrtph.2013.10.003. Epub 2013 Oct 23.
6
QSSPN: dynamic simulation of molecular interaction networks describing gene regulation, signalling and whole-cell metabolism in human cells.QSSPN:描述人类细胞中基因调控、信号转导和整体细胞代谢的分子相互作用网络的动态模拟。
Bioinformatics. 2013 Dec 15;29(24):3181-90. doi: 10.1093/bioinformatics/btt552. Epub 2013 Sep 23.
7
Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data.在药代动力学建模中结合“自下而上”和“自上而下”方法:将生理药代动力学(PBPK)模型与观察到的临床数据进行拟合。
Br J Clin Pharmacol. 2015 Jan;79(1):48-55. doi: 10.1111/bcp.12234.
8
Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development.药物发现与开发中基于生理的药代动力学建模的基本概念。
CPT Pharmacometrics Syst Pharmacol. 2013 Aug 14;2(8):e63. doi: 10.1038/psp.2013.41.
9
The determination and interpretation of the therapeutic index in drug development.药物研发中治疗指数的确定和解读。
Nat Rev Drug Discov. 2012 Oct;11(10):751-61. doi: 10.1038/nrd3801. Epub 2012 Aug 31.
10
Human tissue in the evaluation of safety and efficacy of new medicines: a viable alternative to animal models?人体组织在新药安全性和有效性评估中的应用:动物模型的可行替代方案?
ISRN Pharm. 2011;2011:806789. doi: 10.5402/2011/806789. Epub 2011 Jul 6.